Maravai LifeSciences Holdings, Inc. Increase (Decrease) in Accrued Liabilities
Maravai LifeSciences Holdings, Inc. (MRVI) reported Increase (Decrease) in Accrued Liabilities of -$3.52 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $1.81M, a 62.20% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$5.34M, a 390.32% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$13.51M.
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $2.25M.
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was -$4.63M.
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was -$23.74M, a 254.58% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $15.36M, a 80.62% increase from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $8.50M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$3.52M 10-Q · filed 2026-08-07 | -$17.04M derived: sum of 3 quarters · filed 2026-08-07 | -$14.79M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$5.34M 10-Q · filed 2026-05-08 | -$18.85M derived: sum of 2 quarters · filed 2026-05-08 | -$16.60M derived: sum of 3 quarters · filed 2026-05-08 | -$11.80M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | -$13.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$11.27M derived: sum of 2 quarters · filed 2026-02-26 | -$6.46M derived: sum of 3 quarters · filed 2026-08-07 | -$4.63M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $2.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $7.05M derived: sum of 2 quarters · filed 2026-08-07 | $8.89M 10-Q · filed 2025-11-07 | $7.32M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $4.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $6.64M 10-Q · filed 2026-08-07 | $7.37M 10-Q · filed 2025-08-11 | $5.08M derived: sum of 3 quarters · filed 2026-08-07 | $4.02M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | $1.84M 10-Q · filed 2026-05-08 | $1.46M 10-Q · filed 2025-05-12 | $274.00K derived: sum of 2 quarters · filed 2026-05-08 | -$783.00K derived: sum of 3 quarters · filed 2026-05-08 | $2.21M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | -$1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.62M derived: sum of 2 quarters · filed 2026-02-26 | $376.00K derived: sum of 3 quarters · filed 2026-02-26 | -$23.74M 10-K · filed 2026-02-26 | -$22.75M 10-K · filed 2025-03-18 | |||
| 2024-09-30 | -$1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.94M derived: sum of 2 quarters · filed 2025-11-07 | -$22.18M 10-Q · filed 2025-11-07 | -$21.12M 10-Q · filed 2024-11-12 | -$15.78M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$21.12M 10-Q · filed 2025-08-11 | -$14.72M derived: sum of 3 quarters · filed 2026-02-26 | -$12.34M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$24.12M 10-Q · filed 2025-05-12 | -$17.72M derived: sum of 2 quarters · filed 2026-02-26 | -$15.34M derived: sum of 3 quarters · filed 2026-02-26 | -$32.98M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.78M derived: sum of 2 quarters · filed 2026-02-26 | -$8.87M derived: sum of 3 quarters · filed 2026-02-26 | $15.36M 10-K · filed 2026-02-26 | $15.11M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$15.26M derived: sum of 2 quarters · filed 2024-11-12 | $8.96M 10-Q · filed 2024-11-12 | $3.35M derived: sum of 4 quarters · filed 2025-03-18 | ||||
| 2023-06-30 | -$17.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $6.58M 10-Q · filed 2024-08-08 | $971.00K derived: sum of 3 quarters · filed 2025-03-18 | $16.86M derived: sum of 4 quarters · filed 2025-03-18 | ||||
| 2023-03-31 | $24.23M 10-Q · filed 2024-05-09 | $18.61M derived: sum of 2 quarters · filed 2025-03-18 | $34.50M derived: sum of 3 quarters · filed 2025-03-18 | $36.79M derived: sum of 4 quarters · filed 2025-03-18 | ||||
| 2022-12-31 | -$5.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $10.28M derived: sum of 2 quarters · filed 2025-03-18 | $12.56M derived: sum of 3 quarters · filed 2025-03-18 | $8.50M 10-K · filed 2025-03-18 | ||||
| 2022-09-30 | $15.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $18.18M derived: sum of 2 quarters · filed 2023-11-08 | $14.11M 10-Q · filed 2023-11-08 | $21.58M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$1.77M 10-Q · filed 2023-08-08 | $5.70M derived: sum of 3 quarters · filed 2024-02-29 | $7.31M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | -$4.06M 10-Q · filed 2023-05-09 | $3.41M derived: sum of 2 quarters · filed 2024-02-29 | $5.03M derived: sum of 3 quarters · filed 2024-02-29 | $3.23M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $7.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $9.09M derived: sum of 2 quarters · filed 2024-02-29 | $7.29M derived: sum of 3 quarters · filed 2024-02-29 | -$3.46M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$181.00K derived: sum of 2 quarters · filed 2022-11-04 | -$10.93M 10-Q · filed 2022-11-04 | -$10.08M 10-Q · filed 2021-11-15 | -$1.99M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | -$1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$12.54M 10-Q · filed 2022-08-05 | -$13.92M 10-Q · filed 2021-08-11 | -$3.60M derived: sum of 3 quarters · filed 2023-02-28 | $2.82M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | -$10.75M 10-Q · filed 2022-05-06 | -$11.04M 10-Q · filed 2021-05-12 | -$1.81M derived: sum of 2 quarters · filed 2023-02-28 | $4.62M derived: sum of 3 quarters · filed 2023-02-28 | -$2.01M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $8.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $15.36M derived: sum of 2 quarters · filed 2023-02-28 | $8.73M derived: sum of 3 quarters · filed 2023-02-28 | $17.78M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $6.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$206.00K derived: sum of 2 quarters · filed 2021-11-15 | $8.84M 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | -$6.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $2.42M 10-Q · filed 2021-08-11 | ||||||
| 2020-03-31 | $9.04M 10-Q · filed 2021-05-12 | |||||||
| 2019-12-31 | $3.50M 10-K · filed 2022-03-01 |